The FDA adverse-event record for pig

Pig Adverse Event Insights

The FDA Center for Veterinary Medicine database holds 1,064 adverse event reports for Pig, distributed across 21 distinct breeds currently tracked in the system. Of those reports, 519 involved a death outcome, producing a 48.8% case-fatality rate among reported events, which reflects reporting severity bias rather than true population mortality. These figures are aggregated directly from openFDA's Animal & Veterinary Adverse Events endpoint and update as new voluntary submissions flow through pet owners, veterinarians, and drug manufacturers.

The most frequently reported clinical signs for Pig are Death (387 reports), Lack of efficacy - NOS (101 reports), Anaphylaxis (85 reports), Death by euthanasia (84 reports), with Death leading the reaction traffic at 387 submissions. On the product side, Narasin is the single most-referenced drug with 147 reports, followed by Gonadotropin Releasing Factor (Gnrf) - Diphtheria Toxoid Conjugate (126), Ractopamine Hydrochloride (95), Tiamulin (80). This combination surfaces which therapeutic classes generate the most adverse event chatter for this species, a useful starting point when comparing Pig reporting patterns against other companion animals in the dataset.

Of the 1,264 Pig reports with a coded outcome, Died accounts for the largest share at 36.6%. Annual submission volume spans 2,010 to 2,025 reports across the 16 years on file, a range that reflects evolving owner awareness, veterinary reporting habits, and new product approvals rather than stable underlying incidence. The breed-level table below breaks these patterns down further, showing how the 21 tracked pig breeds compare on volume, deaths, and average age at report. As with all FDA adverse event data, correlation is the ceiling, causation requires clinical investigation beyond what these aggregates can provide.